N-benzylpiperazine has characteristics of a drug of abuse

Behavioural Pharmacology

Volumn 18, Issue 8, 2007, Pages 785-790

  Brennan, Katharine A ^a,b   Lake, Barbara ^b   Hely, Lincoln S ^b   Jones, Karen ^b   Gittings, David ^b   Colussi Mas, Joyce ^b   Fitzmaurice, Paul S ^a   Lea, Rod A ^a   Schenk, Susan ^b  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Abuse potential; Acquisition; Benzylpiperazine; Cocaine; D1 like receptors; Rat; Self administration; Substitution

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; N BENZYLPIPERAZINE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; DOPAMINERGIC ACTIVITY; DRUG ABUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; RAT; TREATMENT RESPONSE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; STREET DRUGS;

EID: 35948942335     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3282f18d8f     Document Type: Article

References (49)

1. Ahmed SH, Koob GF (2004). Changes in response to a dopamine receptor antagonist in rats with escalating cocaine intake. Psychopharmacology (Berl) 172:450-454.
2. Alex KD, Pehek EA (2007). Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296-320.
3. Andrews CM, Lucki I (2001). Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens. Psychopharmacology (Berl) 155:221-229.
4. Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (2005). N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Neuropsychopharmacology 30:550-560.
5. Bradberry CW, Nobiletti JB, Elsworth JD, Murphy B, Jatlow P, Roth RH (1993). Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem 60:1429-1435.
6. Brennan K, Johnstone A, Fitzmaurice P, Lea R, Schenk S (2007). Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA). Drug Alcohol Depend 88:204-213.
7. Bye C, Munro-Faure AD, Peck AW, Young PA (1973). A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests. Eur J Clin Pharmacol 6:163-169.
8. Campbell H, Cline W, Evans M, Lloyd J, Peck AW (1973). Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. Eur J Clin Pharmacol 6:170-176.
9. Chen NH, Reith ME (1994). Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships. J Neurochem 63:1701-1713.
10. Daniela E, Brennan K, Gittings D, Hely L, Schenk S (2004). Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol Biochem Behav 77:745-750.
11. DEA (2004). Drug enforcement administration: schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into schedule I of the Controlled Substances Act. Final rule. Fed Regist 69:12794-12797.
12. Deneau G, Yanagita T, Seevers MH (1969). Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16:30-48.
13. Di Chiara G (2000). Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295-314.
14. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274-5278.
15. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, et al. (2004). Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (Suppl 1):227-241.
16. EACD (2004). The Expert Advisory Committee on Drugs: Advice To the minister on benzylpiperazine (BZP). National Drug Policy http://www.ndp.govt.nz/ legalpartypills/documents/eacd-report-bzp-april2004.pdf. [Accessed 240807].
17. Essman WD, Singh A, Lucki I (1994). Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine. Pharmacol Biochem Behav 49:107-113.
18. Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A (2005). Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug Alcohol Depend 77:161-168.
19. Fergusson DM, Horwood LJ (2000). Does cannabis use encourage other forms of illicit drug use? Addiction 95:505-520.
20. Fergusson DM, Boden JM, Horwood LJ (2006). Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 101: 556-569.
21. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J (1995). The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90:607-614.
22. Griffiths RR, Bigelow GE, Liebson I (1978). Experimental drug self-administration: generality across species and type of drug. NIDA Res Monogr 20:24-43.
23. Hemby SE, Co C, Koves TR, Smith JE, Dworkin SI (1997). Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology (Berl) 133:7-16.
24. Hoffman DC (1989). The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res Bull 23:373-387.
25. Horger BA, Shelton K, Schenk S (1990). Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav 37:707-711.
26. Johnson PB, Boles SM, Kleber HD (2000). The relationship between adolescent smoking and drinking and likelihood estimates of illicit drug use. J Addict Dis 19:75-81.
27. Johnstone A, Lea RA, Brennan KA, Schenk S, Kennedy MA, Fitzmaurice PS (2007). Benzylpiperazine: a drug of abuse? J Psychopharmacology (Berl) (in press).
28. Kandel DB, Yamaguchi K, Chen K (1992). Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 53:447-457.
29. Koob GF, Le HT, Creese I (1987). The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett 79:315-320.
30. Lau CE, Sun L (2002). The pharmacokinetic determinants of the frequency and pattern of intravenous cocaine self-administration in rats by pharmacokinetic modeling. Drug Metab Dispos 30:254-261.
31. Lessem JM, Hopfer CJ, Haberstick BC, Timberlake D, Ehringer MA, Smolen A, Hewitt JK (2006). Relationship between adolescent marijuana use and young adult illicit drug use. Behav Genet 36:498-506.
32. Lindsay GB, Rainey J (1997). Psychosocial and pharmacologic explanations of nicotine's 'gateway drug' function. J Sch Health 67:123-126.
33. Lynskey MT, Heath AC, Bucholz KK, Slutske WS, Madden PA, Nelson EC, et al. (2003). Escalation of drug use in early-onset cannabis users vs. co-twin controls. Jama 289:427-433.
34. Mets B, Diaz J, Soo E, Jamdar S (1999). Cocaine, norcocaine, ecgonine methylester and benzoylecgonine pharmacokinetics in the rat. Life Sci 65:1317-1328.
35. MHRA (2007). Press release: benzylpiperazine (PEP) pills are dangerous and illegal. http://www.mhra.gov.uk/home/idcplg?IdcService= SS_GET_PAGE&useSecondary=true&ssDocName=CON2030603&ssTargetNodeId= 389. [Accessed 240807].
36. NDPSC (2006). National Drugs and Poisons Schedule Committee 46th Meeting. http://www.tga.gov.au/ndpsc/record/rr200602.pdf. [Accessed 240807].
37. NFS (2007). Slimfast: triple action weight management formula. http://www.slimfast.net.nz/. [Accessed 240807].
38. Reith ME, Li MY, Yan QS (1997). Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology (Berl) 134:309-317.
39. Schenk S, Gittings D (2003). Effects of SCH 23390 and eticlopride on cocaine seeking produced by cocaine and WIN 35,428 in rats. Psychopharmacology (Berl) 168:118-123.
40. Schenk S, Worley CM, McNamara C, Valadez A (1996). Acute and repeated exposure to caffeine: effects on reinstatement of extinguished cocaine-taking behavior in rats. Psychopharmacology (Berl) 126:17-23.
41. Schenk S, Gittings D, Johnstone M, Daniela E (2003). Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl) 169:21-27.
42. Schuster CR, Thompson T (1969). Self administration of and behavioral dependence on drugs. Annu Rev Pharmacol 9:483-502.
43. Spealman RD, Goldberg SR (1978). Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu Rev Pharmacol Toxicol 18:313-339.
44. STANZ (2005). Submission of the Social Tonics Association of New Zealand to the Health Select Committee on the Matter of Misuse of Drugs Amendment Bill (No 3). http://www.stanz.org.nz/ SOP%20Submission%20for%20STANZ%20%20%20Jan%2020052.pdf. [Accessed 240807].
45. Topp L, Mattick RP (1997). Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 92:839-845.
46. Tsutsumi H, Katagi M, Miki A, Shima N, Kamata T, Nakajima K, et al. (2006). Metabolism and the urinary excretion profile of the recently scheduled designer drug N-Benzylpiperazine (BZP) in the rat. J Anal Toxicol 30:38-43.
47. Wilkins C, Girling M, Sweetsur P, Huckle T, Huakau J (2006).'National Household Survey-Legal party pill use in New Zealand: prevalence of use, availability, health harms and 'gateway effects' of benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP).'
48. Worley CM, Valadez A, Schenk S (1994). Reinstatement of extinguished cocainetaking behavior by cocaine and caffeine. Pharmacol Biochem Behav 48:217-221.
49. Yokel RA, Piekens R (1974). Drug level of D and L-amphetamine during intravenous self-administration. Psychopharmacologia 34:255-264.